Large-scale testing (Phase 3)Active Not RecruitingNCT06799000
What this trial is testing
Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 588